Canadian Guidelines on Alcohol, Benzodiazepine, Cannabis and Opioid Use Disorder Among Older Adults

Guideline Development Methodology

In 2017, the CCSMH was awarded funding by Health Canada’s Substance Use and Addictions Program (SUAP), to develop four sets of clinical guidelines on the prevention, screening, assessment, and treatment of Alcohol Use Disorder (AUD), Benzodiazepine Receptor Agonist Use Disorder (BUD), Cannabis Use Disorder (CUD) and Opioid Use Disorder (OUD) in older adults. This document outlines the methodology that was followed in the development of these four clinical guidelines.

Alcohol Use Disorder

Benzodiazepine Use Disorder

Cannabis Use Disorder

Opioid Use Disorder